These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35581626)

  • 21. Are the current thresholds, indicators, and time window for cold warning effective enough to protect cardiovascular health?
    Lin S; Lawrence WR; Lin Z; DiRienzo S; Lipton K; Dong GH; Leung R; Lauper U; Nasca P; Stuart N
    Sci Total Environ; 2018 Oct; 639():860-867. PubMed ID: 29929324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Household energy efficiency and health: Area-level analysis of hospital admissions in England.
    Sharpe RA; Machray KE; Fleming LE; Taylor T; Henley W; Chenore T; Hutchcroft I; Taylor J; Heaviside C; Wheeler BW
    Environ Int; 2019 Dec; 133(Pt A):105164. PubMed ID: 31518939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimating the future burden of cardiovascular disease and the value of lipid and blood pressure control therapies in China.
    Stevens W; Peneva D; Li JZ; Liu LZ; Liu G; Gao R; Lakdawalla DN
    BMC Health Serv Res; 2016 May; 16():175. PubMed ID: 27165638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-Sectional Analysis of the Relationship Between Home Blood Pressure and Indoor Temperature in Winter: A Nationwide Smart Wellness Housing Survey in Japan.
    Umishio W; Ikaga T; Kario K; Fujino Y; Hoshi T; Ando S; Suzuki M; Yoshimura T; Yoshino H; Murakami S;
    Hypertension; 2019 Oct; 74(4):756-766. PubMed ID: 31446802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of training community health workers and their interventions on cardiovascular disease risk factors among adults in Morogoro, Tanzania: study protocol for a cluster randomized controlled trial.
    Muhihi AJ; Urassa DP; Mpembeni RNM; Leyna GH; Sunguya BF; Kakoko D; Kessy AT; Njelekela MA
    Trials; 2018 Oct; 19(1):552. PubMed ID: 30314511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimated prevalence of cardiovascular disease and distribution of cardiovascular risk in New Zealanders: data for healthcare planners, funders, and providers.
    Wells S; Broad J; Jackson R
    N Z Med J; 2006 Apr; 119(1232):U1935. PubMed ID: 16633394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study.
    Roth GA; Mensah GA; Johnson CO; Addolorato G; Ammirati E; Baddour LM; Barengo NC; Beaton AZ; Benjamin EJ; Benziger CP; Bonny A; Brauer M; Brodmann M; Cahill TJ; Carapetis J; Catapano AL; Chugh SS; Cooper LT; Coresh J; Criqui M; DeCleene N; Eagle KA; Emmons-Bell S; Feigin VL; Fernández-Solà J; Fowkes G; Gakidou E; Grundy SM; He FJ; Howard G; Hu F; Inker L; Karthikeyan G; Kassebaum N; Koroshetz W; Lavie C; Lloyd-Jones D; Lu HS; Mirijello A; Temesgen AM; Mokdad A; Moran AE; Muntner P; Narula J; Neal B; Ntsekhe M; Moraes de Oliveira G; Otto C; Owolabi M; Pratt M; Rajagopalan S; Reitsma M; Ribeiro ALP; Rigotti N; Rodgers A; Sable C; Shakil S; Sliwa-Hahnle K; Stark B; Sundström J; Timpel P; Tleyjeh IM; Valgimigli M; Vos T; Whelton PK; Yacoub M; Zuhlke L; Murray C; Fuster V;
    J Am Coll Cardiol; 2020 Dec; 76(25):2982-3021. PubMed ID: 33309175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet count and indoor cold exposure among elderly people: A cross-sectional analysis of the HEIJO-KYO study.
    Saeki K; Obayashi K; Kurumatani N
    J Epidemiol; 2017 Dec; 27(12):562-567. PubMed ID: 28645521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea.
    Liew D; Park HJ; Ko SK
    Clin Ther; 2009 Oct; 31(10):2189-203; discussion 2150-1. PubMed ID: 19922890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gazing through time and beyond the health sector: Insights from a system dynamics model of cardiovascular disease in Australia.
    Peng CQ; Lawson KD; Heffernan M; McDonnell G; Liew D; Lybrand S; Pearson SA; Cutler H; Kritharides L; Trieu K; Huynh Q; Usherwood T; Occhipinti JA
    PLoS One; 2021; 16(9):e0257760. PubMed ID: 34591888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness analysis of population salt reduction interventions to prevent cardiovascular disease in Cameroon: mathematical modelling study.
    Aminde LN; Cobiac L; Veerman JL
    BMJ Open; 2020 Nov; 10(11):e041346. PubMed ID: 33234652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimated health benefits, costs, and cost-effectiveness of eliminating industrial trans-fatty acids in Australia: A modelling study.
    Marklund M; Zheng M; Veerman JL; Wu JHY
    PLoS Med; 2020 Nov; 17(11):e1003407. PubMed ID: 33137090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cause-specific cardiovascular disease mortality attributable to ambient temperature: A time-stratified case-crossover study in Jiangsu province, China.
    Xu R; Shi C; Wei J; Lu W; Li Y; Liu T; Wang Y; Zhou Y; Chen G; Sun H; Liu Y
    Ecotoxicol Environ Saf; 2022 May; 236():113498. PubMed ID: 35421825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Thermal and Lighting Housing Environments and Circadian Blood Pressure Variability: Findings from the HEIJO-KYO Cohort].
    Obayashi K; Saeki K
    Nihon Eiseigaku Zasshi; 2018; 73(2):138-142. PubMed ID: 29848864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How Does Preterm Delivery Contribute to the Increased Burden of Cardiovascular Disease? Quantifying the Economic Impact of Cardiovascular Disease in Women with a History of Preterm Delivery.
    Gao L; Li SC; Moodie M
    J Womens Health (Larchmt); 2020 Nov; 29(11):1392-1400. PubMed ID: 32150481
    [No Abstract]   [Full Text] [Related]  

  • 36. Association between arthritis and cardiovascular risk factors in community-based adults: an opportunity to target cardiovascular risk.
    Sewell J; Hussain SM; Wang Y; Wluka AE; Lim YZ; Carrington MJ; Samaras K; Cicuttini FM
    BMC Cardiovasc Disord; 2022 May; 22(1):232. PubMed ID: 35590252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Burden of cardiovascular risk factors and disease among patients with type 1 diabetes: results of the Australian National Diabetes Audit (ANDA).
    Pease A; Earnest A; Ranasinha S; Nanayakkara N; Liew D; Wischer N; Andrikopoulos S; Zoungas S
    Cardiovasc Diabetol; 2018 Jun; 17(1):77. PubMed ID: 29859534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Future burden of cardiovascular disease in Australia: impact on health and economic outcomes between 2020 and 2029.
    Marquina C; Talic S; Vargas-Torres S; Petrova M; Abushanab D; Owen A; Lybrand S; Thomson D; Liew D; Zomer E; Ademi Z
    Eur J Prev Cardiol; 2022 May; 29(8):1212-1219. PubMed ID: 33686414
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.